Suppr超能文献

意大利南部一名93岁患者罕见地由[此处原文缺失具体病菌名称]引起尿路感染。

Rare case of urinary tract infection caused by in a 93-year-old patient in southern Italy.

作者信息

Aveta Achille, Napodano Giorgio, Spena Gianluca, Contieri Roberto, Perdonà Sisto, Pinchera Biagio, Pandolfo Savio Domenico

机构信息

Department of Neurosciences and Reproductive Sciences and Odontostomatology, University of Naples "Federico II", 80131 Naples, Italy.

Department of Urology, ASL NA1 Centro Ospedale del Mare, 80147 Naples, Italy.

出版信息

Infez Med. 2025 Jun 1;33(2):221-225. doi: 10.53854/liim-3302-8. eCollection 2025.

Abstract

is a rare Gram-negative bacterium that has been infrequently associated with human infections. It is a non-encapsulated, facultative anaerobic organism that grows well in nonselective laboratory media and exhibits variable resistance patterns. Although has been identified as a pathogen since 2006, reports of its clinical significance remain scarce, particularly in Europe. Here, we present the case of a 93-year-old male from Southern Italy, with multiple comorbidities and a history of urinary catheterization, who developed a urinary tract infection (UTI) caused by . The patient was successfully treated with ciprofloxacin and fosfomycin, achieving clinical and microbiological healing. This report examines the substantial challenges associated with rare pathogens in clinical practice, focusing on the critical need for prompt and precise identification alongside tailored treatment strategies. Additionally, it highlights the pathogen's alarming multidrug resistance capabilities, underscoring the urgent need for robust antimicrobial stewardship programs and comprehensive research into its epidemiological behavior and resistance mechanisms. Incorporating rare pathogens into differential diagnoses, particularly for elderly patients with recurrent UTIs, could improve patient outcomes significantly. Finally, these findings expand the limited existing data on infections, providing valuable insights into more precise diagnostic methodologies and tailored therapeutic approaches.

摘要

是一种罕见的革兰氏阴性菌,很少与人类感染相关。它是一种无荚膜的兼性厌氧菌,在非选择性实验室培养基中生长良好,且表现出可变的耐药模式。尽管自2006年以来已被确认为病原体,但其临床意义的报道仍然很少,尤其是在欧洲。在此,我们报告一例来自意大利南部的93岁男性病例,该患者有多种合并症且有导尿史,他发生了由 引起的尿路感染(UTI)。患者接受环丙沙星和磷霉素治疗成功,实现了临床和微生物学治愈。本报告探讨了临床实践中与罕见病原体相关的重大挑战,重点关注及时准确识别以及量身定制治疗策略的迫切需求。此外,它突出了该病原体令人担忧的多重耐药能力,强调了强有力的抗菌药物管理计划以及对其流行病学行为和耐药机制进行全面研究的迫切需求。将罕见病原体纳入鉴别诊断,特别是对于复发性UTI的老年患者,可显著改善患者预后。最后,这些发现扩展了关于 感染的有限现有数据,为更精确的诊断方法和量身定制的治疗方法提供了有价值的见解。

相似文献

1
Rare case of urinary tract infection caused by in a 93-year-old patient in southern Italy.
Infez Med. 2025 Jun 1;33(2):221-225. doi: 10.53854/liim-3302-8. eCollection 2025.
2
Death related to Cedecea lapagei in a soft tissue bullae infection: a case report.
J Med Case Rep. 2018 Nov 3;12(1):328. doi: 10.1186/s13256-018-1866-x.
4
Case Report: Cedecea lapagei Infection: Report of a Case in Peru and Review of the Literature.
Am J Trop Med Hyg. 2023 Jun 20;109(2):356-367. doi: 10.4269/ajtmh.23-0168. Print 2023 Aug 2.
5
First report of pneumonia and septic shock caused by in Vietnam.
New Microbes New Infect. 2020 May 23;36:100698. doi: 10.1016/j.nmni.2020.100698. eCollection 2020 Jul.
7
Cedecea lapagei in a patient with malignancy: Report of a rare case.
J Cancer Res Ther. 2015 Jul-Sep;11(3):646. doi: 10.4103/0973-1482.147736.
8
First reported case of pneumonia caused by Cedecea lapagei in America.
Braz J Infect Dis. 2013 Sep-Oct;17(5):626-8. doi: 10.1016/j.bjid.2013.03.003. Epub 2013 Sep 11.
9
[A pneumonia case caused by Cedecea lapagei].
Mikrobiyol Bul. 2008 Oct;42(4):681-4.
10
[Cedecea lapagei traumatic wound infection: case report and literature review].
Rev Chilena Infectol. 2013 Feb;30(1):86-9. doi: 10.4067/S0716-10182013000100015.

本文引用的文献

2
Antibiotic Resistance Patterns Among Uropathogens in Female Outpatients Affected by Uncomplicated Cystitis: Focus on Fosfomycin Trometamol.
Int J Antimicrob Agents. 2023 Nov;62(5):106974. doi: 10.1016/j.ijantimicag.2023.106974. Epub 2023 Sep 20.
3
Case Report: Cedecea lapagei Infection: Report of a Case in Peru and Review of the Literature.
Am J Trop Med Hyg. 2023 Jun 20;109(2):356-367. doi: 10.4269/ajtmh.23-0168. Print 2023 Aug 2.
5
Characterization of Two Novel AmpC Beta-Lactamases from the Emerging Opportunistic Pathogen, .
Antibiotics (Basel). 2023 Jan 20;12(2):219. doi: 10.3390/antibiotics12020219.
6
Genomic Insights into Drug Resistance Determinants in , A Rare Opportunistic Pathogen.
Microorganisms. 2021 Aug 15;9(8):1741. doi: 10.3390/microorganisms9081741.
8
Expanding spectrum of opportunistic Cedecea infections: Current clinical status and multidrug resistance.
Int J Infect Dis. 2020 Nov;100:461-469. doi: 10.1016/j.ijid.2020.09.036. Epub 2020 Sep 17.
9
First report of pneumonia and septic shock caused by in Vietnam.
New Microbes New Infect. 2020 May 23;36:100698. doi: 10.1016/j.nmni.2020.100698. eCollection 2020 Jul.
10
Nosocomial pneumonia and sepsis caused by a rare organism in an infant and a review of literature.
BMJ Case Rep. 2019 Jul 11;12(7):e229854. doi: 10.1136/bcr-2019-229854.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验